FindTrial
Sign In

MISAGO stent Post Marketing Surveillance

MISAGO stent Post Marketing Surveillance - MISAGO PMS

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000026875
Enrollment
250
Registered
2017-04-05
Start date
2013-01-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral arterial disease of lower extremities by a stenotic or occlusive de novo lesion at SFA/PA

Interventions

None listed

Sponsors

Terumo Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: nothing

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

MeasureTime frame
Stent thrombosis, stent fracture and TLR incidence—

Countries

Japan

Contacts

Public ContactYouko Ogata

Terumo Corporation Clinical Development Department

Youko_Ogata@terumo.co.jp0465-81-4126

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026